An enhanced expression of TIGIT on tumor-infiltrating CD8+ and CD4+ T cells in HNSCC patients was correlated with CD8+ functional exhaustion and impaired activation and proliferation as well as with the expression with other immune checkpoint molecules such as PD-1 [78]. Here, TIGIT is linked to head and neck squamous cell carcinoma.